🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a prospective, multicenter, open label extension (OLE) trial on th...
Status
Terminated
Location
Investigator site 115 - US0010086
Start Date
2021-07-15
Trial ID
NCT04598477
Treatments Being Tested
A phase 1 study in healthy volunteers (female and male) to evaluate through...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-09
Trial ID
NCT03457649
The study is a Randomized, Open-label, Parallel Group Study to Compare the ...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2017-10-11
Trial ID
NCT03334084
Treatments Being Tested
The purpose of this study is to evaluate the safety of efgartigimod PH20 SC...
Status
Terminated
Location
Medical Dermatology Specialists
Start Date
2023-03-22
Trial ID
NCT05681481
Treatments Being Tested
This is an open-label long-term multicenter phase 3 trial to evaluate the e...
Status
Completed
Location
Investigator Site 0010045
Start Date
2020-06-02
Trial ID
NCT04225156
Treatments Being Tested
This is a phase 3, multicenter, randomized, double-blinded, placebo-control...
Status
Completed
Location
Investigator Site 0010116
Start Date
2020-12-16
Trial ID
NCT04687072
Treatments Being Tested
This is a randomized, double-blind placebo-controlled multicenter phase 3 t...
Status
Completed
Location
Investigator Site 0010038
Start Date
2019-12-16
Trial ID
NCT04188379
Treatments Being Tested
A Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 su...
Status
Active Not Recruiting
Location
Investigator Site 0010116
Start Date
2021-11-17
Trial ID
NCT04812925
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, multicenter Phase I...
Status
Completed
Location
Investigator Site 19
Start Date
2016-12-30
Trial ID
NCT02965573
The aim of this trial is to investigate the pharmacodynamic (PD), pharmacok...
Status
Completed
Location
Investigator Site
Start Date
2019-07-17
Trial ID
NCT04073589
Treatments Being Tested